Pfizer Hit With $6.3M Prempro Verdict In Pa.

By Erin Marie Daly

Law360, New York (November 20, 2009, 5:43 PM ET) -- A Pennsylvania jury has ruled that two Pfizer Inc. units are on the hook for at least $6.3 million in compensatory damages to an Illinois woman who developed breast cancer after she began taking popular menopause drugs Prempro and Provera.

On Friday, Bloomberg News reported that the jury in the Philadelphia County Court of Common Pleas had issued the verdict after finding that the combination of Wyeth’s Prempro and Pharmacia & Upjohn’s Provera substantially contributed to 66-year-old plaintiff Donna Kendall’s breast cancer.

The jury's award marks...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles